{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T05:07:20Z","timestamp":1717218440804},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T00:00:00Z","timestamp":1347926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00595-012-0339-x","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T11:14:08Z","timestamp":1347880448000},"page":"171-174","source":"Crossref","is-referenced-by-count":1,"title":["A giant Krukenberg tumor from a perforated gastric cancer that was successfully removed after multidisciplinary therapy: report of a case"],"prefix":"10.1007","volume":"44","author":[{"given":"Masaki","family":"Sunagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Isogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kaneoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuyuki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,18]]},"reference":[{"key":"339_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jso.20072","volume":"87","author":"JH Cheong","year":"2004","unstructured":"Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH. Surgical management and outcome of metachronous Krukenberg tumors from gastric cancer. J Surg Oncol. 2004;87:39\u201345.","journal-title":"J Surg Oncol"},{"key":"339_CR2","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","volume":"29","author":"M Sasako","year":"2011","unstructured":"Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29:4387\u201393.","journal-title":"J Clin Oncol"},{"key":"339_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2008","unstructured":"Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215\u201321.","journal-title":"Lancet Oncol."},{"key":"339_CR4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00595-010-4403-0","volume":"41","author":"T Okuyama","year":"2011","unstructured":"Okuyama T, Korenaga D, Koushi K, Itoh S, Kawanaka H, Ikeda Y, et al. The prognostic significance of chemotherapy for stage IV gastric cancer patients: a single-institution experience. Surg Today. 2011;41:935\u201340.","journal-title":"Surg Today"},{"key":"339_CR5","first-page":"2662","volume":"46","author":"H Nakano","year":"1999","unstructured":"Nakano H, Namatame K, Nemoto H, Motohashi H, Nishiyama K, Kumada K, Kanagawa Lentinan Research Group. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Hepatogastroenterology. 1999;46:2662\u20138.","journal-title":"Hepatogastroenterology"},{"key":"339_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1142\/S0192415X94000371","volume":"22","author":"Y Horie","year":"1994","unstructured":"Horie Y, Kato K, Kameoka S, Hamano K. Bu ji (hozai) for treatment of postoperative gastric cancer patients. Am J Chin Med. 1994;22:309\u201319.","journal-title":"Am J Chin Med"},{"key":"339_CR7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/0002-9378(65)90178-X","volume":"93","author":"SL Israel","year":"1965","unstructured":"Israel SL, Helsel EV Jr, Hausman DH. The challenge of metastatic ovarian carcinoma. Am J Obstet Gynecol. 1965;93:1094\u2013101.","journal-title":"Am J Obstet Gynecol."},{"key":"339_CR8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejso.2008.05.006","volume":"35","author":"R Jiang","year":"2009","unstructured":"Jiang R, Tang J, Cheng X, Zang RY. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors. Eur J Surg Oncol. 2009;35:92\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"339_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2003.12.039","volume":"93","author":"RG Moore","year":"2004","unstructured":"Moore RG, Chung M, Granai CO, Gajewski W, Steinhoff MM. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol. 2004;93:87\u201391.","journal-title":"Gynecol Oncol"},{"key":"339_CR10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/gyno.1997.4793","volume":"66","author":"TC Chang","year":"1997","unstructured":"Chang TC, Changchien CC, Tseng CW, Lai CH, Tseng CJ, Lin SE, et al. Retrograde lymphatic spread: a likely route for metastatic ovarian cancers of gastrointestinal origin. Gynecol Oncol. 1997;66:372\u20137.","journal-title":"Gynecol Oncol"},{"key":"339_CR11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2003.04.130","volume":"21","author":"A Ohtsu","year":"2003","unstructured":"Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, et al. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). J Clin Oncol. 2003;21:54\u20139.","journal-title":"J Clin Oncol"},{"key":"339_CR12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5306\/wjco.v2.i10.339","volume":"2","author":"K Ina","year":"2011","unstructured":"Ina K, Furuta R, Kataoka T, Kayukawa S, Yoshida T, Miwa T, et al. Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy. World J Clin Oncol. 2011;2:339\u201343.","journal-title":"World J Clin Oncol."}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-012-0339-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-012-0339-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-012-0339-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T14:00:27Z","timestamp":1559138427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-012-0339-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,18]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1007\/s00595-012-0339-x","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,18]]}}}